Functional impairment in patients with major depressive disorder and comorbid anxiety disorder

Canadian Journal of Psychiatry

Volumn 58, Issue 12, 2013, Pages 679-686

  Gili, Margalida ^a,b   Toro, Mauro García ^a,b   Armengol, Silvia ^c   García Campayo, Javier ^d   Castro, Adoración ^a   Roca, Miquel ^a,b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Grupo Cardiovascular de Baleares de la Red de investigación en Actividades Preventivas y Promoción de la Salud en Atención Primaria REDIAP   (Spain)

^c Almirall Medical Department ^*  (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Anxiety; Comorbidity; Depression; Disability; Functional impairment

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEPRESSION; DISABILITY; FEMALE; FUNCTIONAL DISEASE; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT CARE; PHYSICAL ACTIVITY; SELF REPORT; STATE TRAIT ANXIETY INVENTORY; SYMPTOMATOLOGY;

ANXIETY; COMORBIDITY; DEPRESSION; DISABILITY; FUNCTIONAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERSONALITY; PERSONALITY INVENTORY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84890366582     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305801205     Document Type: Article

References (54)

1. Murray CJ, Lopez A, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.
2. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet. 2007;370(9590):859-877.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
4. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747-1757.
5. Lam RW, Michalack EE, Bond DJ, et al. Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depress Res Treat. 2012;2012:630206. doi: 10.1155/2012/630206.
6. Ormel J, VonKorff M, Ustun TB, et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA. 1994;272(22):1741-1748.
7. Ormel J, Kempen GI, Deeg DJ, et al. Functioning, well-being, and health perception in late middle-aged and older people: comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc. 1998;46(1):39-48.
8. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major US corporation. Am J Psychiatry. 2000;157(8):1274-1278.
9. Gili M, Luciano JV, Serrano MJ, et al. Mental disorders among frequent attenders in primary care: a comparison with routine attenders. J Nerv Ment Dis. 2011;199(10):744-749.
10. Plaisier I, de Graaf R, de Bruijin J, et al. Depressive and anxiety disorders on-the-job: the importance of job characteristics for good work functioning in persons with depressive and anxiety disorders. Psychiatry Res. 2012;200:382-388.
11. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1998;262(7):914-919.
12. Judd LL, Akiskal HS, Zeller PJ, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57(4):375-380.
13. Papakostas GI, Petersen T, Mahal Y, et al. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004;26:13-17.
14. Ormel J, Petukhova M, Chatterji S. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry. 2008;192(5):368-375.
15. Bromberger JT, di Scalea TL. Longitudinal associations between depression and functioning in midlife women. Maturitas. 2009;64(3):145-159.
16. Rhebergen D, Beekman AT, de Graaf R. et al. Trajectories of recovery of social and physical functioning in major depression, dysthymic disorder and double depression: a 3-year follow-up. J Affect Disord. 2010;124(1-2):148-156.
17. Godard J, Baruch P, Grondin S, et al. Psychosocial and neurocognitive functioning in unipolar and bipolar depression: a 12-month prospective study. Psychiatry Res. 2012;196:145-153.
18. Iosifescu DV. The relation between mood, cognition and psychosocial functioning in psychiatric disorders. Eur Neuropsychopharmacol. 2012;22(3):499-504.
19. Kruijshaar ME, Hoeymans N, Bijl RV, et al. Levels of disability in major depression: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord. 2003;77(1):53-64.
20. Solomon DA, Leon AC, Endicott J, et al. Psychosocial impairment and recurrence of major depression. Compr Psychiatry. 2004;45(6):423-430.
21. Van der Werff E, Verboom CE, Penninx BW, et al. Explaining heterogeneity in disability associated with current major depressive disorder: effects of illness characteristics and comorbid mental disorders. J Affect Disord. 2010;127(1-3):203-210.
22. Verboom CE, Sentse M, Sijtsema JJ, et al. Explaining heterogeneity in disability with major depressive disorder: effects of personal and environmental characteristics. J Affect Disord. 2011;132(1-2):71-81.
23. Fichter MM, Quadflieg N, Fischer UC, et al. Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatr Scand. 2010;122(1):75-85.
24. Klein Hofmeijer-Sevink M, Batelaan NM, van Megen HJ, et al. Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2012;137(1-3):106-112.
25. Belzer K, Schneier FR. Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment. J Psychiatr Pract. 2004;10(5):296-306.
26. Brown TA, Campbell LA, Lehman CL, et al. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110(4):585-599.
27. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
28. Roca M, Gili M, Garcia-Garcia M, et al. Prevalence and comorbidity of common mental disorders in primary care. J Affect Disord. 2009;119(1-3):52-58.
29. Meng X, D'Arcy C. Common and unique risk factors and comorbidity for 12-month mood and anxiety disorders among canadians. Can J Psychiatry. 2012;57(8):479-487.
30. Lenze EJ, Mulsant BH, Shear MK, et al. Comorbidity of depression and anxiety disorders in later life. Depress Anxiety. 2012;14(2):86-93.
31. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
32. Penninx BW, Nolen WA, Lamers F, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2001;133(1-2):76-85.
33. Kessler R, White LA, Birnbaum H, et al. Comparative and interactive effects of depression relative to other health problems on work performance in the workforce of a large employer. J Occup Environ Med. 2008;50(7):809-816.
34. Lam RW, Filteau MJ, Milev R. Clinical effectiveness: the importance of psychosocial functioning outcomes. J Affect Disord. 2011;(132):S9-S13.
35. Zayfert C, Dums AR, Ferguson RJ, et al. Health functioning impairments associated with posttraumatic stress disorder, anxiety disorders and depression. J Nerv Ment Dis. 2002;190(4):233-240.
36. World Health Organization (WHO). Disability Assessment Schedule II (WHO-DAS II) [Internet]. Geneva (CH): WHO; 2005 [cited 2013 Jun 28]. Available from: http://www.who.int/classifications/icf/en/.
37. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. Washignton (DC): APA; 2000.
38. Vázquez-Barquero JL, Vázquez E, Herrera S, et al. Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): initial phase of development and pilot study. Cantabria disability work group. Actas Esp Psiquiatr. 2000;28:77-87.
39. Luciano JV, Ayuso-Mateos JL, Fernández A, et al. Psychometric properties of the twelve item World Health Organization Disability Assessment Schedule II (WHO-DAS-II) in Spanish primary care patients with a first major depressive episode. J Affect Disord. 2010;121:52-58.
40. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
41. Lobo A, Chamorro L, Luque A, et al. [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales]. Med Clin (Barc). 2002;118(13):493-499. Spanish.
42. Spielberger CD, Gorsuch R, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto (CA): Consulting Psychologist Press; 1970.
43. Spielberger CD, Díaz-Guerrero R. Cross-cultural anxiety (vol 3). Washington (DC): Hemisphere/Wiley; 1986.
44. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583.
45. University of Pittsburgh. IDS/QIDS. Instruments in English and multiple translations [Internet]. Pittsburgh (PA): University of Pittsburgh; 2013 [cited 2013 Jun 28]. Available from: http://www.ids-qids.org/tr-spanish.html.
46. Kessler RC, DuPont RL, Berglund P, et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry. 1999;156(12):1915-1923.
47. Wittchen H, Carter RM, Pfister H, et al. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000;15(6):319-328.
48. Plaisier I, Beekman de Graaf RA, Smit JH, et al. Work functioning in persons with depressive and anxiety disorders: the role of specific psychopathological characteristics. J Affect Disord. 2010;125:198-206.
49. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry. 1996;30:17-20.
50. Meng X, D'arcy C. Common and unique risk factors and comorbidity for 12-month mood and anxiety disorders among Canadians. Can J Psychiatry. 2012;57(8):479-487.
51. Bronisch T, Hecht H. Major depression with and without a coexisting anxiety disorder: social dysfunction, social integration, and personality features. J Affect Disord. 1990;20(3):151-157.
52. Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex and stressful life events in the prediction of episodes or major depression. Am J Psychiatry. 2004;161:631-636.
53. Hettema JM. What is the genetic relationship between anxiety and depression? Am J Med Gen C Semin Med Genet. 2008;148C:140-146.
54. Sandi C, Richter-Levin G. From high anxiety trait to depression: a neurocognitive hyphotesis. Trends Neurosci. 2009;32(6):312-320.